Clinical trials: Non-Diabetic Disorder of Endocrine Pancreas
Non-Diabetic Disorder of Endocrine Pancreas
Glucose Tolerance, Meal Timing and MTNR1B
The purpose of this investigation is to assess in a community-based cohort of late-night eaters the effect of coincident food intake and endogenous melatonin on glycemic control, and the putative interaction effect of melatonin…
- Trial name
- ONTIME-DINE (NCT03003936)
- Testing
- Dinner timing
- Where
- Spain
- Volunteers
- 280 people, healthy volunteers welcome
- Sponsor
- Universidad de Murcia
Non-Diabetic Disorder of Endocrine Pancreas
MTNR1B SNP*Food Timing Interaction on Glucose Control
The purpose of this investigation is to assess the role of melatonin receptor 1B (MTNR1B) single nucleotide polymorphism (SNP)*food timing interaction on glucose control in the deleterious effect in a vulnerable population with…
- Trial name
- ONTIME-MT (NCT03036592)
- Testing
- Early OGTT, Late OGTT
- Where
- Spain
- Volunteers
- 889 people, healthy volunteers welcome
- Sponsor
- Universidad de Murcia
Cystic Fibrosis
Glycemic Monitoring in Cystic Fibrosis
Current guidelines on the diagnoses and management of cystic fibrosis (CF) related diabetes recommend treatment for diabetes based on diagnostic criteria derived from adults with type 2 diabetes.
- Trial name
- GEM (NCT02211235)
- Where
- United States
- Volunteers
- 146 people, healthy volunteers welcome
- Sponsor
- University of Colorado, Denver
Diabetes, Insulin Resistance
Measurement of the Pancreas Function in Patients With More Than One Pancreas After Liver and Small Bowel Transplantation
Under chronic immunosuppressive and corticosteroid therapy, transplant patients have a tendency to develop in the long-term diabetes.
- Conditions
- Diabetes, Insulin Resistance, Liver/Small Bowel Transplant
- Trial name
- NCT01621516
- Volunteers
- 6 people, healthy volunteers welcome
- Sponsor
- KU Leuven